Patents by Inventor Mette KJAER

Mette KJAER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
    Patent number: 9834613
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: December 5, 2017
    Assignee: PROPHYLIX PHARMA AS
    Inventors: Bjorn Skogen, Anne Husebekk, Mette Kjaer, Jens Kjeldsen-Kragh
  • PREPARATION USEFUL FOR, AND METHOD FOR TREATMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
    Publication number: 20160215062
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA 1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Applicant: PROPHYLIX PHARMA AS
    Inventors: Bjorn SKOGEN, Anne HUSEBEKK, Mette KJAER, Jens KJELDSEN-KRAGH
  • PREPARATION USEFUL FOR, AND METHOD FOR TREATMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
    Publication number: 20140377283
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Inventors: Bjorn SKOGEN, Anne HUSEBEKK, Mette Kjaer KILLIE, Jens KJELDSEN-KRAGH
  • Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT)
    Patent number: 8840897
    Abstract: A preparation useful for, and a method for the prophylactic treatment of women post-childbirth in order to avoid immunization and antibody production, which could induce NAIT and fetal/neonatal bleeding in subsequent pregnancies comprising administering a preparation containing antibodies to HPA1a within 72 hours after delivery in the first non-compatible pregnancy.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: September 23, 2014
    Assignee: Prophylix Pharma AS
    Inventors: Bjorn Skogen, Anne Husse-Bekk, Mette Kjaer Killie, Jens Kjeldsen-Kragh